Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL22390477

O=C(O)C(F)(F)F.O=C(O)Cc1ccc(CN2C[C@@H]3CNCCN3C2=O)cc1

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ENPP2 Q13822 3/20 0.39
▸ SLC2A1 P11166 1/20 0.36
▸ DPP4 P27487 3/20 0.35
▸ F2 P00734 2/20 0.35
▸ F10 P00742 2/20 0.35
▸ HPN P05981 1/20 0.35
▸ PRSS1 P07477 1/20 0.35
▸ PRSS2 P07478 1/20 0.35
▸ PRSS3 P35030 1/20 0.35
▸ HGFAC Q04756 1/20 0.35
▸ ST14 Q9Y5Y6 1/20 0.35
▸ LMNA P02545 1/20 0.34
▸ HTR2C P28335 6/20 0.34
▸ HTR2B P41595 6/20 0.34
▸ HTR2A P28223 5/20 0.34
▸ KCNJ1 P48048 1/20 0.34
▸ TACR1 P25103 1/20 0.34
▸ POLB P06746 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20942315 0.93 ENPP2 (0.43) ENPP2DPP4F2F10HPN
Trifluoroacetic Acid SCHEMBL31655669 0.89 F10 (0.39) SLC2A1DPP4F2F10HPN
Trifluoroacetic Acid SCHEMBL22390335 0.85 F2 (0.39) F2F10HTR2CHTR2BHTR2A
SCHEMBL22390478 0.85 SCN9A (0.34) DPP4F2F10HPNPRSS1
SCHEMBL17062837 0.82 F10 (0.42) DPP4F2F10HPNPRSS1
SCHEMBL29516262 0.80 SIGMAR1 (0.47) F2F10HPNPRSS1PRSS2
Trifluoroacetic Acid SCHEMBL31655667 0.80 ITGB3 (0.36) HTR2CHTR2BHTR2ASCN9A
SCHEMBL20616288 0.79 F10 (0.40) ENPP2F2F10HPNPRSS1
SCHEMBL20616290 0.79 F10 (0.40) ENPP2F2F10HPNPRSS1
Hydrochloric Acid SCHEMBL3602646 0.79 SIGMAR1 (0.46) F2F10HPNPRSS1PRSS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11261190-B2 Dihydropyrimidine compounds and uses thereof in medicine SUNSHINE LAKE PHARMA CO., LTD. (CN) 2022-03-01 — — US disclosed
US-20200283445-A1 DIHYDROPYRIMIDINE COMPOUNDS AND USES THEREOF IN MEDICINE SUNSHINE LAKE PHARMA CO., LTD. (CN) 2020-09-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200283445-A1 DIHYDROPYRIMIDINE COMPOUNDS AND USES THEREOF IN MEDICINE TPMT, DPYD, SLC10A1 ENPP2 3137/4885SLC2A1 854/4885DPP4 166/4885
US-11261190-B2 Dihydropyrimidine compounds and uses thereof in medicine DPYD, TPMT, SLC10A1 ENPP2 3033/4885SLC2A1 921/4885DPP4 228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback